These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26787500)

  • 21. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
    Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
    J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.
    Li Y; Huang S; Huang X; Li X; Falcon A; Soutar A; Bornancin F; Jiang Z; Xin HB; Fu M
    Cell Signal; 2018 Oct; 50():1-8. PubMed ID: 29913212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Malt1 protease activity in pathogenesis of inflammatory disorders mediated by FcγR signaling.
    Nakamura Y; Yokoyama K; Igaki K; Tsuchimori N
    Int Immunopharmacol; 2018 Mar; 56():193-196. PubMed ID: 29414650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of new Malt1 inhibitors and probes.
    Xin BT; Schimmack G; Du Y; Florea BI; van der Marel GA; Driessen C; Krappmann D; Overkleeft HS
    Bioorg Med Chem; 2016 Aug; 24(15):3312-29. PubMed ID: 27085674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.
    Yu JW; Hoffman S; Beal AM; Dykon A; Ringenberg MA; Hughes AC; Dare L; Anderson AD; Finger J; Kasparcova V; Rickard D; Berger SB; Ramanjulu J; Emery JG; Gough PJ; Bertin J; Foley KP
    PLoS One; 2015; 10(5):e0127083. PubMed ID: 25965667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attacking MALT1 for ABC-DLBCL therapy.
    Krappmann D
    Oncotarget; 2012 Dec; 3(12):1489-90. PubMed ID: 23455231
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.
    Vicente-Dueñas C; Fontán L; Gonzalez-Herrero I; Romero-Camarero I; Segura V; Aznar MA; Alonso-Escudero E; Campos-Sanchez E; Ruiz-Roca L; Barajas-Diego M; Sagardoy A; Martinez-Ferrandis JI; Abollo-Jimenez F; Bertolo C; Peñuelas I; Garcia-Criado FJ; García-Cenador MB; Tousseyn T; Agirre X; Prosper F; Garcia-Bragado F; McPhail ED; Lossos IS; Du MQ; Flores T; Hernandez-Rivas JM; Gonzalez M; Salar A; Bellosillo B; Conde E; Siebert R; Sagaert X; Cobaleda C; Sanchez-Garcia I; Martinez-Climent JA
    Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10534-9. PubMed ID: 22689981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain.
    Kip E; Staal J; Verstrepen L; Tima HG; Terryn S; Romano M; Lemeire K; Suin V; Hamouda A; Kalai M; Beyaert R; Van Gucht S
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29367251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting B-cell lymphomas with inhibitors of the MALT1 paracaspase.
    Hailfinger S; Lenz G; Thome M
    Curr Opin Chem Biol; 2014 Dec; 23():47-55. PubMed ID: 25285878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.
    Kip E; Staal J; Tima HG; Verstrepen L; Romano M; Lemeire K; Suin V; Hamouda A; Baens M; Libert C; Kalai M; Van Gucht S; Beyaert R
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30158289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
    Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM
    Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.
    Fontán L; Qiao Q; Hatcher JM; Casalena G; Us I; Teater M; Durant M; Du G; Xia M; Bilchuk N; Chennamadhavuni S; Palladino G; Inghirami G; Philippar U; Wu H; Scott DA; Gray NS; Melnick A
    J Clin Invest; 2018 Oct; 128(10):4397-4412. PubMed ID: 30024860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of recombinant and cellular MALT1 paracaspase activity.
    Nagel D; Krappmann D
    Methods Mol Biol; 2015; 1280():239-46. PubMed ID: 25736752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling.
    Juilland M; Thome M
    Front Immunol; 2018; 9():1927. PubMed ID: 30214442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.
    Nagel D; Spranger S; Vincendeau M; Grau M; Raffegerst S; Kloo B; Hlahla D; Neuenschwander M; Peter von Kries J; Hadian K; Dörken B; Lenz P; Lenz G; Schendel DJ; Krappmann D
    Cancer Cell; 2012 Dec; 22(6):825-37. PubMed ID: 23238017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.
    Hathcock KS; Padilla-Nash HM; Camps J; Shin DM; Triner D; Shaffer AL; Maul RW; Steinberg SM; Gearhart PJ; Staudt LM; Morse HC; Ried T; Hodes RJ
    Blood; 2015 Nov; 126(20):2291-301. PubMed ID: 26400962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting MALT1 for the treatment of diffuse large B-cell lymphoma.
    Seshadri MR; Melnick AM
    Leuk Lymphoma; 2022 Apr; 63(4):789-798. PubMed ID: 34783281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.
    Tusche MW; Ward LA; Vu F; McCarthy D; Quintela-Fandino M; Ruland J; Gommerman JL; Mak TW
    J Exp Med; 2009 Nov; 206(12):2671-83. PubMed ID: 19917778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
    Safa FM; Rasmussen T; Fontan L; Xia M; Melnick A; Wiestner A; Lobelle-Rich P; Burger JA; Mouawad Y; Safah H; Flemington EK; Saba NS
    Haematologica; 2024 May; 109(5):1348-1358. PubMed ID: 37767562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical Probes for Profiling of MALT1 Protease Activity.
    Verhelst SHL; Prothiwa M
    Chembiochem; 2023 Nov; 24(21):e202300444. PubMed ID: 37607867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.